Annette Bakker

3.5k total citations · 1 hit paper
61 papers, 2.3k citations indexed

About

Annette Bakker is a scholar working on Molecular Biology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Annette Bakker has authored 61 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Neurology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Annette Bakker's work include Neurofibromatosis and Schwannoma Cases (14 papers), Sarcoma Diagnosis and Treatment (9 papers) and Mitochondrial Function and Pathology (8 papers). Annette Bakker is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (14 papers), Sarcoma Diagnosis and Treatment (9 papers) and Mitochondrial Function and Pathology (8 papers). Annette Bakker collaborates with scholars based in United States, Belgium and Italy. Annette Bakker's co-authors include Bart Vanhaesebroeck, Klaus Schulze‐Osthoff, Rudi Beyaert, Walter Fiers, Michel Janicot, Douglas W. Smith, Marco Rossi, W. Jacob, Nico Janssens and Letizia Magnoni and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Annette Bakker

59 papers receiving 2.3k citations

Hit Papers

Cytotoxic activity of tumor necrosis factor is mediated b... 1992 2026 2003 2014 1992 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Bakker United States 23 1.4k 288 285 264 247 61 2.3k
Alice Lau United States 26 1.2k 0.8× 260 0.9× 156 0.5× 254 1.0× 135 0.5× 45 2.1k
Daisuke Tsuchimoto Japan 28 1.8k 1.3× 334 1.2× 407 1.4× 195 0.7× 312 1.3× 50 2.6k
Mary F. Lopez United States 33 2.2k 1.5× 274 1.0× 145 0.5× 229 0.9× 282 1.1× 86 3.6k
Yan‐Hui Liu China 27 1.5k 1.0× 271 0.9× 171 0.6× 190 0.7× 264 1.1× 152 2.7k
Theodoros I. Roumeliotis United Kingdom 23 1.4k 1.0× 333 1.2× 253 0.9× 153 0.6× 248 1.0× 60 2.4k
Sun‐Il Hwang United States 22 1.8k 1.2× 304 1.1× 416 1.5× 161 0.6× 354 1.4× 44 2.7k
David Meierhofer Germany 30 1.8k 1.3× 445 1.5× 129 0.5× 365 1.4× 155 0.6× 84 2.9k
Yingxin Zhao United States 34 1.9k 1.3× 337 1.2× 470 1.6× 303 1.1× 353 1.4× 86 3.0k
Xin A. Zhang United States 34 1.6k 1.1× 377 1.3× 406 1.4× 218 0.8× 413 1.7× 62 3.4k
Gerd Birkenmeier Germany 27 1.2k 0.8× 292 1.0× 398 1.4× 129 0.5× 138 0.6× 92 2.3k

Countries citing papers authored by Annette Bakker

Since Specialization
Citations

This map shows the geographic impact of Annette Bakker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Bakker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Bakker more than expected).

Fields of papers citing papers by Annette Bakker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Bakker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Bakker. The network helps show where Annette Bakker may publish in the future.

Co-authorship network of co-authors of Annette Bakker

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Bakker. A scholar is included among the top collaborators of Annette Bakker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Bakker. Annette Bakker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plotkin, Scott R., Kaleb Yohay, Phioanh L. Nghiemphu, et al.. (2024). Brigatinib in NF2 -Related Schwannomatosis with Progressive Tumors. New England Journal of Medicine. 390(24). 2284–2294. 11 indexed citations
2.
Rhodes, Steven D., Frank McCormick, Ross Cagan, et al.. (2023). RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights. Journal of Investigative Dermatology. 143(8). 1358–1368. 2 indexed citations
3.
Bakker, Annette, et al.. (2022). Collaboration in Research for Rare Disease: How Nonprofits can be the Change Makers. 5(1). 1 indexed citations
4.
Ferner, Rosalie E., D. Gareth Evans, Angela M. Kaindl, et al.. (2021). Lessons learned from drug trials in neurofibromatosis: A systematic review. European Journal of Medical Genetics. 64(9). 104281–104281. 2 indexed citations
5.
Li, Shufeng, et al.. (2020). Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry. JCI Insight. 5(16). 18 indexed citations
6.
Rosa, Salvatore La, Annette Bakker, Jaishri O. Blakeley, et al.. (2019). Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors. EMBO Molecular Medicine. 12(1). e11656–e11656. 4 indexed citations
7.
Allaway, Robert J., Salvatore La Rosa, Sharad K. Verma, et al.. (2019). Engaging a community to enable disease-centric data sharing with the NF Data Portal. Scientific Data. 6(1). 319–319. 11 indexed citations
8.
Ferner, Rosalie E., Annette Bakker, Ype Elgersma, et al.. (2019). From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis. American Journal of Medical Genetics Part A. 179(6). 1098–1106. 6 indexed citations
10.
Pratelli, Carmela, Massimiliano Salerno, Patrizia Tunici, et al.. (2015). Structure–activity relationship and properties optimization of a series of Quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway. European Journal of Medicinal Chemistry. 95. 526–545. 15 indexed citations
11.
Setoaín, Javier, Mónica Franch, Marta Martínez, et al.. (2015). NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning. Nucleic Acids Research. 43(W1). W193–W199. 48 indexed citations
12.
Rossi, Marco, Letizia Magnoni, Clelia Miracco, et al.. (2011). β-catenin and Gli1 are prognostic markers in glioblastoma. Cancer Biology & Therapy. 11(8). 753–761. 89 indexed citations
13.
Bakker, Annette, et al.. (2006). Targeting the p53 tumor suppressor gene function in glioblastomas using small chemical molecules. Drug Development Research. 67(10). 790–800. 1 indexed citations
14.
Janssens, Nico, et al.. (2004). Alteration of Frizzled Expression in Renal Cell Carcinoma. Tumor Biology. 25(4). 161–171. 40 indexed citations
15.
Pun, Suzie H., Nathalie C. Bellocq, Jianjun Cheng, et al.. (2004). Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles. Cancer Biology & Therapy. 3(7). 641–650. 156 indexed citations
17.
Nollin, Sonja De, et al.. (1997). Molecular Identification of Foreign Inclusions in Inflammatory Tissue Surrounding Metal Implants by Fourier Transform Laser Microprobe Mass Spectrometry. Pathology - Research and Practice. 193(4). 313–318. 7 indexed citations
18.
Bakker, Annette, Sonja De Nollin, Luc Van Vaeck, et al.. (1995). Lidocaine does not prevent the calcium paradox in rat hearts: A laser microprobe mass analysis (LAMMA) study. Life Sciences. 56(19). 1601–1611. 2 indexed citations
20.
Bakker, Annette & Douglas W. Smith. (1989). Methylation of GATC sites is required for precise timing between rounds of DNA replication in Escherichia coli. Journal of Bacteriology. 171(10). 5738–5742. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026